Anteris Technologies Global (AVR) Gains from Sales and Divestitures (2025)

Anteris Technologies Global (AVR) reported Gains from Sales and Divestitures of $685847.0 for Q4 2025.

Anteris Technologies Global (AVR) has 1 years of Gains from Sales and Divestitures data on file, last reported at $685847.0 in Q4 2025.

  • Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $685847.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $685847.0 (changed N/A YoY) and the FY2025 annual result came in at $685847.0, changed N/A from the prior year.
  • Gains from Sales and Divestitures was little changed at $685847.0 in Q4 2025 per AVR's latest filing.
  • Across five years, Gains from Sales and Divestitures topped out at $685847.0 in Q4 2025 and bottomed at $685847.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Anteris Technologies Global 753.31 Mn 753.28 Mn 380,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 685,847.00
Dec 31, 2025 685,847.00